Healthcare group Fresenius warned over Puerto Rico plant
Aug 23 (Reuters) - U.S. regulators have issued a third warning this year for German healthcare group Fresenius to improve procedures at its sites, this time a blood bag manufacturing plant in Puerto Rico. A letter to the company from the U.S. Food and Drug Administration (FDA) took issue with complaint-handling procedures and labelling at the Puerto Rico site, the German company said on Friday, adding that patients had not been put at risk. Fresenius said that it is addressing the concerns raised by the FDA and that production at the plant is continuing, adding that full-year earnings targets for the infusion drugs and b...
Source: PharmaGossip - August 24, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs